Business Description
Pernix Therapeutics Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US71426V3069
Compare
Compare
Traded in other countries / regions
IPO Date
1997-02-07Description
Pernix Therapeutics Holdings Inc is a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs. It aims at underserved therapeutic areas, such as central nervous system, including neurology, pain, and psychiatry. Its products include Treximet used to treat acute migraine; Zohydro ER with BeadTek, an extended-release opioid agonist indicated used in case of severe pain; Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance, and Khedezla for major depressive disorder. Geographically all the operations are functioned though the United States, however also has a business presence in international market.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -94.74 | |||||
| 12-1 Month Momentum % | -99.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -71.52 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PTXTQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pernix Therapeutics Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 127.924 | ||
| EPS (TTM) ($) | -6.49 | ||
| Beta | 0 | ||
| Volatility % | 111.08 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | -99.21 | ||
| 52-Week Range ($) | 0.02 - 2.65 | ||
| Shares Outstanding (Mil) | 14.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pernix Therapeutics Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pernix Therapeutics Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pernix Therapeutics Holdings Inc Frequently Asked Questions
What is Pernix Therapeutics Holdings Inc(PTXTQ)'s stock price today?
The current price of PTXTQ is $0.03. The 52 week high of PTXTQ is $2.65 and 52 week low is $0.02.
When is next earnings date of Pernix Therapeutics Holdings Inc(PTXTQ)?
The next earnings date of Pernix Therapeutics Holdings Inc(PTXTQ) is .
Does Pernix Therapeutics Holdings Inc(PTXTQ) pay dividends? If so, how much?
Pernix Therapeutics Holdings Inc(PTXTQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers